{"created":"2014-10-03T21:21:42+00:00","modified":"2014-10-31T02:17:14+00:00","valid":{"from":"2014-10-31T02:17:14+00:00","to":"3014-10-31T02:17:14+00:00"},"hreflang":"en","title":"Drug Industry Moves To Cut Costs, Banks On Future Big Sellers","published":"2014-05-11T22:32:00+00:00","teaser":"Bayer has announced it is buying Merck's consumer drugs business, and Pfizer is trying to take over AstraZeneca. Why is this reorganization happening now, and what does it mean for drug development?","itags":["npr_api","310630409"],"guid":"62aa81d5-8aee-4ea8-a6f2-df6b98e2963a","contentencoded":"<p><div class=\"fullattribution\">Copyright 2014 NPR. To see more, visit <a href=\"http://www.npr.org/\">http://www.npr.org/</a>.<img src=\"http://www.google-analytics.com/__utm.gif?utmac=UA-5828686-4&utmdt=Drug+Industry+Moves+To+Cut+Costs%2C+Banks+On+Future+Big+Sellers&utme=8(APIKey)9(MDAyOTcwNDAwMDEyODgyMDkwMTgwNzY3YQ001)\"/></div></p>","byline":"Scott Hensley","audio":[{"meta":{"duration":"274"},"type":"audio/m3u","href":"http://api.npr.org/m3u/1310630733-f635a0.m3u?orgId=1&topicId=1006&ft=3&f=310630409"}]}